Global Science and Technology, Inc.

Partnering for Success

Newsroom: News Articles

GST’s Executive Vice President, Dr. Christopher Cheng, recently announced that Global Science & Technology, Inc.

Let's start with a hypothetical. A company spends three years building a team, iterating designs, screening materials, constructing a supply chain, conducting preliminary preclinical and functional evaluations, and building the bones of a design history file for an improved version of an existing medical device. Now it is time to freeze the design and launch costly good laboratory practice (GLP) evaluations necessary for getting approval for a pivotal clinical study.

During the medical device development process, the stakes rise with every stage, transitioning from concept discovery, to design iteration, preclinical testing, clinical testing, and finally, market launch.

Let's start with a hypothetical. A company spends three years building a team, iterating designs, screening materials, constructing a supply chain, conducting preliminary preclinical and functional evaluations, and building the bones of a design history file for an improved version of an existing medical device.

Cardiovascular medical devices are invented and used for a myriad of reasons.  They maintain blood vessel flow lumens, exclude aneurysms and dissections, close orifices and communications, and even completely replace the function of valves, vessels, and membranes.

The National Mesonet Program:  Filling in the Gaps - WeatherWise article, published July 2013

GST Mission: Save lives, Protect Property During Major Weather Events

GST’s Alliance Wins NWS National Mesonet Program Contract

GST Project impacted by next-generation weather satellite

Pages